Astrazeneca (AZN)

 

AZN Share PerformanceMore

52 week high5,505 05/08/16
52 week low3,680 24/06/16
52 week change 1,236 (31.72%)
4 week volume52,578,242 26/04/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

FTSE rises on telecoms and miners

Stronger retailers and telecom stocks helped to offset weakness in housebuilders and insurance companies as the FTSE 100 ...

FTSE opens higher on miners, comm. property

The FTSE got away to a positive start Monday morning with rising miners, commercial property and utilities all helping th...

AZ agreement with Recordati for Seloken

AstraZeneca has entered into an agreement with Recordati for the commercial rights to Seloken/Seloken ZOK (metoprolol...

AZ AGREEMENT WITH RECORDATI FOR SELOKEN IN EUROPE

RNS Number: 7679F AstraZeneca PLC 22 May 2017 22 May 2017 07:00 BST ASTRAZENECA ENTERS AGREEMENT WITH RECORDATI FOR SELOKEN IN EUROPE Agreement expands the commercial potential of Seloken in European markets AstraZeneca to receive upfront payment, plus ongoing income for established heart medicines AstraZeneca announ...

Fund manager's favourite small-cap pharma shares

If you're looking for capital growth, don't bother with big pharma, argues fund manager Paul Mumford. He tells Lee Wild...

Woodford Income Focus versus Equity Income: What's the difference?

Neil Woodford has just unveiled the holdings in his new Income Focus fund and there are lots of familiar names. David B...

Broker Forecast - Liberum Capital issues a broker note on AstraZeneca PLC

Liberum Capital today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to ...

Broker Forecast - Berenberg issues a broker note on AstraZeneca PLC

Berenberg today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 5850p ...

Latest discussion posts More

  • Another bid?

    Would AstraZeneca really find itself contending with another megamerger offer, this time from Novartis? That?s the speculation on the street, and it apparently has investors ...
    16-May-2017
    Proverbs 26 vs 5
  • Re: Positive trial news for lung cancer ...

    "The challenge for investors: the sales of these drugs are increasing much faster than our understanding of the science around them. By the time oncologists really understand ...
    15-May-2017
    Punilux
  • Re: Positive trial news for lung cancer ...

    Thanks very much for info did understand some of it !
    14-May-2017
    paul1945

Users' HoldingsMore

Users who hold Astrazeneca also hold..
GLAXOSMITHKLINE48%
VODAFONE GRP.37%
BP36%
NATIONAL GRID35%
RDS 'B'33%

Codes & Symbols

ISINGB0009895292
SymbolsAZN, LSE:AZN, AZN.L, AZN:LN, LON:AZN, XLON:AZN